Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.47 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.47 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.41 |
| ▸ | ALPI | P09923 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | XIAP | P98170 | 1/20 | 0.40 |
| ▸ | REN | P00797 | 3/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | ACE | P12821 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7269530 | 0.91 | SLC7A5 (0.45) | ANPEPRNPEPDNPEPSLC7A5LTA4H | |
| SCHEMBL11047397 | 0.91 | SLC7A5 (0.48) | SLC7A5LTA4HALPIPKMPTGS1 | |
| SCHEMBL6830232 | 0.87 | ANPEP (0.42) | ANPEPRNPEPDNPEPSLC7A5LTA4H | |
| SCHEMBL27809385 | 0.85 | ANPEP (0.48) | ANPEPRNPEPDNPEPSLC7A5LTA4H | |
| SCHEMBL11651226 | 0.84 | ATM (0.45) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL9321962 | 0.84 | ATM (0.45) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL8392929 | 0.84 | ATM (0.45) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL19974077 | 0.83 | ANPEP (0.51) | ANPEPRNPEPDNPEPSLC7A5LTA4H | |
| SCHEMBL27468737 | 0.83 | ANPEP (0.53) | ANPEPRNPEPDNPEPSLC7A5LTA4H | |
| SCHEMBL6548736 | 0.82 | ITGA4 (0.44) | SLC7A5ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10059736-B2 | Ionic liquid supported synthesis | MCGILL UNIVERSITY (CA) | 2018-08-28 | — | — | US | disclosed |
| US-20100041869-A1 | IONIC LIQUID SUPPORTED SYNTHESIS | MCGILL UNIVERSITY (CA) | 2010-02-18 | — | — | US | disclosed |
| CN-101180307-A | Ionic liquid supported synthesis | UNIV MCGILL (CA) | 2008-05-14 | — | — | CN | disclosed |
| EP-1861413-A1 | IONIC LIQUID SUPPORTED SYNTHESIS | McGILL UNIVERSITY (CA) | 2007-12-05 | — | — | EP | disclosed |
| WO-2006096963-A1 | IONIC LIQUID SUPPORTED SYNTHESIS | MCGILL UNIVERSITY (CA) | 2006-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041869-A1 | IONIC LIQUID SUPPORTED SYNTHESIS | IGF2BP1, IGF2BP2, IGF2BP3 | ANPEP 676/4885RNPEP 258/4885DNPEP 477/4885 |
| US-10059736-B2 | Ionic liquid supported synthesis | IGF2BP1, IGF2BP2, IGF2BP3 | ANPEP 676/4885RNPEP 258/4885DNPEP 477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.